Tirzepatide, a recently approved medication, is generating considerable buzz within the healthcare community. It functions differently from common diabetes medications, targeting multiple receptors involved in glucose regulation and hunger . Initial studies have demonstrated impressive efficacy in controlling blood levels in individuals with type 2